16 reports

The magnitude of the impact has been categorized as described below: ## ## ## ## ## ## ## ## ## ## Low High High Low Low ## ## ## ## ## High High ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Promising drug pipeline Changes in lifestyle Low ## ## ## ## ## High Low

  • Depression
  • Actavis plc
  • Bristol-Myers Squibb Company
  • Eli Lilly & Co.
  • GlaxoSmithKline plc
  • 3.1 ETIOLOGY AND PATHOPHYSIOLOGY

Research; ##(##-##): ##-##.

  • Depression
  • Alkermes plc
  • Allergan plc
  • Lundbeck Inc.
  • Otsuka Pharmaceutical Co., Ltd.

GSK has a diversified portfolio of products and provides assistance in treating major diseases such as asthma, cancer, infections, mental health, diabetes, and digestive conditions, and in viral diseases.

  • Depression
  • United States
  • Actavis plc
  • Eli Lilly & Co.
  • GlaxoSmithKline plc

THE PROMINENT FEATURES OF THIS REPORT ARE - ##.

  • Clinical Trial
  • Depression
  • Pharmaceutical
  • Sleep Aid
  • World
  • XPRO-1595 - DRUG PROFILE
  • DEPRESSION - PIPELINE BY SUMITOMO DAINIPPON PHARMA CO LTD, H2 2017

This patent, which expires in 2032 protects to the use of masitinib in the treatment of severe persistent corticosteroid-dependent asthma and severe persistent corticosteroidresistant asthma.

  • Depression
  • United States
  • Company
  • Product Initiative
  • Anavex Life Sciences Corp.
  • XPRO-1595 - DRUG PROFILE
  • DEPRESSION - PIPELINE BY SUMITOMO DAINIPPON PHARMA CO LTD, H1 2018

As of August 2017, it was in Phase II stage of development for the treatment of severe asthma.

  • Depression
  • United States
  • Company
  • Product Initiative
  • Anavex Life Sciences Corp.

PRESENTED POST APPROVAL STUDY RESULTS AT THE AMERICAN THORACIC SOCIETY INTERNATIONAL CONFERENCE THAT DEMONSTRATED THE ALAIR™ BRONCHIAL THERMOPLASTY SYSTEM REDUCED COMPLICATIONS, INCLUDING SEVERE ASTHMA EXACERBATIONS AND ASTHMA-RELATED HOSPITALIZATIONS, IN ADULT PATIENTS WITH SEVERE

  • Clinical Trial
  • Depression
  • Mental Health
  • Therapy
  • GlobalData's company
  • PIPELINE BY JOHNSON & JOHNSON, H2 2017

The Phase II program consists of two studies, one in adult and one in elderly patients.

  • Depression
  • Pharmaceutical
  • Sleep Aid
  • United States
  • Product Initiative

The prominent features of this report are - ##.

  • Chronic Pain
  • Clinical Trial
  • Depression
  • Pharmaceutical
  • Eli Lilly & Co.

Patients with DRE met zero or one major criteria and one to two minor criteria.

  • Depression
  • Pharmaceutical
  • Therapy
  • United States
  • Lundbeck Inc.
  • SCHIZOPHRENIA - PIPELINE BY SUVEN LIFE SCIENCES LTD

The company offers product such as vaccines for the treatment of cancer types including breast, lung, prostate cancer and melanoma, infectious diseases such as HIV-##, dengue and malaria, chronic diseases such as diabetes, asthma and hyperlipidemia; neurological diseases such as Alz

  • Depression
  • Psychotic Disorder
  • United States
  • Company
  • Product Initiative
  • INSOMNIA - PIPELINE BY NEURIM PHARMACEUTICALS LTD, H2 2017
  • INSOMNIA - PIPELINE BY IDORSIA LTD, H2 2017

Neurim offers treatments for other therapeutic areas that include Parkinson' s disease, and asthma or chronic obstructive pulmonary disease.

  • Depression
  • Psychotic Disorder
  • United States
  • World
  • Product Initiative

It is in Phase II stage of development for the treatment of polymyalgia rheumatica, major depressive disorder and severe asthma.

  • Depression
  • United States
  • Company
  • Product Initiative
  • Allergan plc
  • INSOMNIA - PIPELINE BY REVIVA PHARMACEUTICALS INC, H1 2018
  • INSOMNIA - PIPELINE BY NEURIM PHARMACEUTICALS LTD, H1 2018

Neurim offers treatments for other therapeutic areas that include Parkinson' s disease, and asthma or chronic obstructive pulmonary disease.

  • Depression
  • Sleep Aid
  • United States
  • World
  • Product Initiative

It is a pyrrolidin-##-one derivative.

  • Depression
  • Pharmaceutical
  • United States
  • World
  • Product Initiative
  • Drug Profiles

It is in Phase II stage of development for major depressive disorder and severe asthma.

  • Depression
  • United States
  • Company Operations
  • Product Initiative
  • Allergan plc